Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...

The FDA is changing protocols to prevent contamination of fresh and frozen berries with enteric viruses such as norovirus and ...

In India’s rapidly growing beauty sector, compliance with regulatory standards is not just a legal necessity but also a ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

Patient monitors, used in both healthcare facilities and home settings, display vital patient information including ...